Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2021-07-22 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these transactions comply with listing rules. The document references specific listing rules from the Stock Exchange of Hong Kong and provides confirmations from a director. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about share repurchases and capital changes. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on company buybacks or sales of its own shares.
2021-07-22 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It details repurchases of shares on various dates, quantities, and prices, confirming compliance with listing rules. The content is focused on reporting share repurchase transactions and capital changes, not on financial results, management commentary, or regulatory certifications. The document is a formal disclosure of share repurchase activity, which aligns with the category for reporting company buying back its own shares. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support this classification with high confidence.
2021-07-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these transactions comply with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive data about share repurchases. The content fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback activities. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2021-07-14 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It details repurchases of shares on specific dates, quantities, prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements or earnings data, nor is this a report of management or board changes. It is a regulatory disclosure about share repurchases, which fits the category of Transaction in Own Shares (POS). The document length is over 10,000 characters and contains detailed transactional data, not just an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the best classification is POS.
2021-07-13 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It details repurchases of shares on specific dates, quantities, and prices, confirming compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There is no indication of a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about transactions in the company's own shares, specifically share buybacks. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a substantive disclosure report.
2021-07-12 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It references compliance with Listing Rules of the Hong Kong Stock Exchange, details on issued shares, repurchases, prices, and confirmations by a director. The content focuses on reporting share capital changes and share repurchase activities, which aligns with disclosures about transactions in own shares. The document is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about share capital changes and buybacks. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length (8039 characters) and detailed data support it being the actual disclosure, not just an announcement of a report.
2021-07-09 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.